Total Payments
$18,578
2024 Payments
$27.27
Companies
11
Transactions
50
Medicare Patients
4,912
Medicare Billing
$5.8M
Payment Breakdown by Category
Other$12,172 (65.5%)
Consulting$5,135 (27.6%)
Food & Beverage$1,271 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,172 | 10 | 65.5% |
| Consulting Fee | $5,135 | 4 | 27.6% |
| Food and Beverage | $1,271 | 36 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $14,339 | 24 | $0 (2023) |
| Augmenix, Inc. | $3,816 | 6 | $0 (2018) |
| Myovant Sciences Inc. | $93.08 | 5 | $0 (2022) |
| Telix Pharmaceuticals | $91.14 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $86.16 | 4 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $41.82 | 1 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $29.16 | 1 | $0 (2023) |
| 180 Medical, Inc. | $27.27 | 1 | $0 (2024) |
| PFIZER INC. | $19.67 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $18.36 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.27 | 1 | 180 Medical, Inc. ($27.27) |
| 2023 | $5,496 | 12 | Boston Scientific Corporation ($5,392) |
| 2022 | $8,938 | 25 | Boston Scientific Corporation ($8,696) |
| 2021 | $299.66 | 6 | BOSTON SCIENTIFIC CORPORATION ($250.87) |
| 2018 | $3,534 | 3 | Augmenix, Inc. ($3,534) |
| 2017 | $281.90 | 3 | AUGMENIX, INC. ($281.90) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $27.27 | General |
| 06/23/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Consulting Fee | Cash or cash equivalent | $1,187.50 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 06/02/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $223.50 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 05/31/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: HORMONE THERAPY | ||||||
| 05/12/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,788.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 05/12/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,788.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 05/12/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $312.90 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 04/17/2023 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $75.51 | General |
| Category: Space OAR_URO | ||||||
| 04/08/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 03/10/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 02/09/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Urology | ||||||
| 01/26/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Oncology | ||||||
| 12/21/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: HORMONE THERAPY | ||||||
| 12/02/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,788.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/02/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,788.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/02/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $312.90 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 11/30/2022 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/28/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $447.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 11/23/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Urology | ||||||
| 11/07/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $68.67 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 11/04/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $223.50 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 10/14/2022 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/01/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: rezum_URO | ||||||
| 09/26/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 799 | 4,830 | $3.4M | $914,678 |
| 2022 | 24 | 1,196 | 5,572 | $4.3M | $1.1M |
| 2021 | 23 | 1,589 | 18,651 | $8.2M | $2.3M |
| 2020 | 23 | 1,328 | 16,812 | $5.3M | $1.4M |
Total Patients
4,912
Total Services
45,865
Medicare Billing
$5.8M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 91 | 1,684 | $1.9M | $514,909 | 26.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 94 | 1,701 | $649,782 | $171,746 | 26.4% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 44 | 46 | $276,184 | $69,654 | 25.2% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 86 | 434 | $257,362 | $67,701 | 26.3% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 87 | 450 | $112,950 | $32,829 | 29.1% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 44 | 47 | $71,581 | $17,823 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $36,541 | $10,244 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 65 | $29,356 | $8,273 | 28.2% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 48 | 131 | $27,248 | $7,002 | 25.7% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 47 | 48 | $25,248 | $6,382 | 25.3% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 56 | 58 | $23,142 | $5,547 | 24.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 15 | $5,855 | $1,108 | 18.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 27 | 31 | $1,891 | $558.62 | 29.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 20 | 22 | $1,892 | $556.38 | 29.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 41 | $1,025 | $344.40 | 33.6% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 73 | 1,675 | $1.9M | $526,046 | 27.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 78 | 1,709 | $652,838 | $174,276 | 26.7% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 73 | 77 | $462,308 | $118,363 | 25.6% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2022 | 16 | 75 | $285,825 | $65,491 | 22.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 75 | 411 | $243,723 | $63,751 | 26.2% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2022 | 13 | 13 | $132,860 | $33,670 | 25.3% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2022 | 73 | 88 | $134,024 | $33,172 | 24.8% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2022 | 89 | 433 | $108,683 | $30,248 | 27.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 31 | 130 | $46,020 | $19,037 | 41.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 100 | 100 | $63,900 | $16,403 | 25.7% |
About Dr. Thomas Pugh, MD
Dr. Thomas Pugh, MD is a Radiation Oncology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174679799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Pugh, MD has received a total of $18,578 in payments from pharmaceutical and medical device companies, with $27.27 received in 2024. These payments were reported across 50 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,172).
As a Medicare-enrolled provider, Pugh has provided services to 4,912 Medicare beneficiaries, totaling 45,865 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Denver, CO
- Active Since 01/26/2007
- Last Updated 06/17/2020
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1174679799
Products in Payments
- SpaceOAR VUE System - 10mL (Device) $13,994
- SpaceOAR (Device) $3,816
- SPACEOAR VUE (Device) $250.87
- ORGOVYX (Drug) $122.24
- ILLUCCIX (Drug) $91.14
- Myrbetriq (Drug) $86.16
- SpaceOAR System (Device) $75.51
- Halcyon (Device) $41.82
- XTANDI (Drug) $19.67
- Xofigo (Drug) $18.36
- rezum Generator (Device) $18.33
- ERLEADA (Drug) $16.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Denver
Seth Reiner, M.d, M.D
Radiation Oncology — Payments: $2,104
Radiation Oncology $2,104
Dr. Eugene Chung, M.d, M.D
Radiation Oncology — Payments: $1,257
Radiation Oncology $1,257
Dr. Mark Chidel, Md, MD
Radiation Oncology — Payments: $532.57
Radiation Oncology $532.57
Dr. Ari Ballonoff, Md, MD
Radiation Oncology — Payments: $455.59
Radiation Oncology $455.59
Christopher Deig, M.d, M.D
Radiation Oncology — Payments: $366.83
Radiation Oncology $366.83
Dr. Andrzej Wojcieszynski, Md, MD
Radiation Oncology — Payments: $184.34
Radiation Oncology $184.34